The announcement by the Food and Drug Administration applies to millions of Americans who take immune-suppressing medicines because of organ transplants, cancer or other disorders. (AP Photo/Mary Altaffer, File)

By Joshua Moore
Special to the AFRO

The U.S. Food and Drug Administration (FDA) authorized a third booster shot of the COVID vaccine for people with weakened immune systems. This approval is an attempt to decrease the number of new COVID cases caused by the Delta Variant.

Immunocompromised people have conditions that cause their immune systems to be vulnerable. These include transplant recipients, people, cancer patients and people who have HIV, among others. Their immune systems leave them susceptible to contracting COVID-19. 

Although any age group could encounter weak immune systems, the vaccine has not been authorized for children under the age of 12. The age group that has always been most at risk has been people aged 65 or older. 

Studies show that after two doses of the vaccine, the immunocompromised body doesn’t develop enough antibodies to fight against the virus. However, a third dose seems to give the body enough antibodies to stand against the virus.

“A third dose seems to get them over that hump so their bodies could start building that immune response that the rest of us have been building all along,” Edwards said. 

Now that the amendment is approved, those eligible for a third shot could begin getting them immediately. 

Help us Continue to tell OUR Story and join the AFRO family as a member – subscribers are now members!  Join here!